| Ident. | Authors (with country if any) | Title |
|---|
| 000030 |
Yeyan He [République populaire de Chine] ; Chanying Zheng [République populaire de Chine] | [Replication and transmission mechanisms of highly pathogenic human coronaviruses]. |
| 000080 |
Hannah Stower [République populaire de Chine] | Virological assessment of SARS-CoV-2. |
| 000119 |
Ying Liu [République populaire de Chine] ; Albert A. Gayle [Suède] ; Annelies Wilder-Smith [Allemagne, Suède] ; Joacim Rocklöv [Suède] | The reproductive number of COVID-19 is higher compared to SARS coronavirus |
| 000184 |
Naidi Yang [République populaire de Chine] ; Han-Ming Shen [République populaire de Chine] | Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19 |
| 000209 |
| Stop the coronavirus stigma now. |
| 000296 |
Gerard Kian-Meng Goh [Singapour] ; A. Keith Dunker ; James A. Foster [États-Unis] ; Vladimir N. Uversky [États-Unis, Russie] | Rigidity of the Outer Shell Predicted by a Protein Intrinsic Disorder Model Sheds Light on the COVID-19 (Wuhan-2019-nCoV) Infectivity |
| 000342 |
Heshui Shi [République populaire de Chine] ; Xiaoyu Han [République populaire de Chine] ; Nanchuan Jiang [République populaire de Chine] ; Yukun Cao [République populaire de Chine] ; Osamah Alwalid [République populaire de Chine] ; Jin Gu [République populaire de Chine] ; Yanqing Fan [République populaire de Chine] ; Chuansheng Zheng [République populaire de Chine] | Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study |
| 000373 |
Shi Zhao [République populaire de Chine] ; Qianyin Lin [États-Unis] ; Jinjun Ran [République populaire de Chine] ; Salihu S. Musa [République populaire de Chine] ; Guangpu Yang [République populaire de Chine] ; Weiming Wang [République populaire de Chine] ; Yijun Lou [République populaire de Chine] ; Daozhou Gao [République populaire de Chine] ; Lin Yang [République populaire de Chine] ; Daihai He [République populaire de Chine] ; Maggie H. Wang [République populaire de Chine] | Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak |
| 000463 |
Mirko Baglivo [Italie] ; Manuela Baronio [Italie] ; Giuseppe Natalini [Italie] ; Tommaso Beccari [Italie] ; Pietro Chiurazzi [Italie] ; Ezio Fulcheri [Italie] ; Paolo Pietro Petralia [Italie] ; Sandro Michelini [Italie] ; Giovanni Fiorentini [Italie] ; Giacinto Abele Miggiano [Italie] ; Assunta Morresi [Italie] ; Gerolamo Tonini [Italie] ; Matteo Bertelli [Italie] | Natural small molecules as inhibitors of coronavirus lipid-dependent attachment to host cells: a possible strategy for reducing SARS-COV-2 infectivity? |
| 000474 |
Paolo Calligari [Italie] ; Sara Bobone [Italie] ; Giorgio Ricci [Italie] ; Alessio Bocedi [Italie] | Molecular Investigation of SARS-CoV-2 Proteins and Their Interactions with Antiviral Drugs. |
| 000541 |
Shuai Xia [République populaire de Chine] ; Meiqin Liu [République populaire de Chine] ; Chao Wang [République populaire de Chine] ; Wei Xu [République populaire de Chine] ; Qiaoshuai Lan [République populaire de Chine] ; Siliang Feng [République populaire de Chine] ; Feifei Qi [République populaire de Chine] ; Linlin Bao [République populaire de Chine] ; Lanying Du [États-Unis] ; Shuwen Liu [République populaire de Chine] ; Chuan Qin [République populaire de Chine] ; Fei Sun [République populaire de Chine] ; Zhengli Shi [République populaire de Chine] ; Yun Zhu [République populaire de Chine] ; Shibo Jiang [République populaire de Chine, États-Unis] ; Lu Lu [République populaire de Chine] | Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion |
| 000619 |
Michael Letko [États-Unis] ; Andrea Marzi [États-Unis] ; Vincent Munster [États-Unis] | Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. |
| 000655 |
Abdul Mannan Baig [Pakistan] ; Areeba Khaleeq [Pakistan] ; Usman Ali [Pakistan] ; Hira Syeda [Pakistan] | Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms. |
| 000722 |
Liying Dong [République populaire de Chine] ; Shasha Hu [République populaire de Chine] ; Jianjun Gao [République populaire de Chine] | Discovering drugs to treat coronavirus disease 2019 (COVID-19). |
| 000795 |
B. Robson [États-Unis, Royaume-Uni] | Computers and viral diseases. Preliminary bioinformatics studies on the design of a synthetic vaccine and a preventative peptidomimetic antagonist against the SARS-CoV-2 (2019-nCoV, COVID-19) coronavirus |
| 000849 |
John Nkengasong [Éthiopie] | China’s response to a novel coronavirus stands in stark contrast to the 2002 SARS outbreak response |
| 000853 |
Xiuyuan Ou [République populaire de Chine] ; Yan Liu [République populaire de Chine] ; Xiaobo Lei [République populaire de Chine] ; Pei Li [République populaire de Chine] ; Dan Mi [République populaire de Chine] ; Lili Ren [République populaire de Chine] ; Li Guo [République populaire de Chine] ; Ruixuan Guo [République populaire de Chine] ; Ting Chen [République populaire de Chine] ; Jiaxin Hu [République populaire de Chine] ; Zichun Xiang [République populaire de Chine] ; Zhixia Mu [République populaire de Chine] ; Xing Chen [République populaire de Chine] ; Jieyong Chen [République populaire de Chine] ; Keping Hu [République populaire de Chine] ; Qi Jin [République populaire de Chine] ; Jianwei Wang [République populaire de Chine] ; Zhaohui Qian [République populaire de Chine] | Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV |
| 000913 |
Andrew M. South [États-Unis] ; Debra I. Diz [États-Unis] ; Mark C. Chappell [États-Unis] | COVID-19, ACE2, and the cardiovascular consequences. |
| 000940 |
Ludmila Prokunina-Olsson [États-Unis] ; Noémie Alphonse [Royaume-Uni] ; Ruth E. Dickenson [Royaume-Uni] ; Joan E. Durbin [États-Unis] ; Jeffrey S. Glenn [États-Unis] ; Rune Hartmann [Danemark] ; Sergei V. Kotenko [États-Unis] ; Helen M. Lazear [États-Unis] ; Thomas R. O'Brien [États-Unis] ; Charlotte Odendall [Royaume-Uni] ; Olusegun O. Onabajo [États-Unis] ; Helen Piontkivska [États-Unis] ; Deanna M. Santer [Canada] ; Nancy C. Reich [États-Unis] ; Andreas Wack [Royaume-Uni] ; Ivan Zanoni [États-Unis] | COVID-19 and emerging viral infections: The case for interferon lambda. |
| 000A09 |
Neeltje Van Doremalen [États-Unis] ; Trenton Bushmaker [États-Unis] ; Dylan H. Morris [États-Unis] ; Myndi G. Holbrook [États-Unis] ; Amandine Gamble [États-Unis] ; Brandi N. Williamson [États-Unis] ; Azaibi Tamin [États-Unis] ; Jennifer L. Harcourt [États-Unis] ; Natalie J. Thornburg [États-Unis] ; Susan I. Gerber [États-Unis] ; James O. Lloyd-Smith [États-Unis] ; Emmie De Wit ; Vincent J. Munster | Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. |
| 000A16 |
Rhian M. Touyz [Royaume-Uni] ; Hongliang Li [République populaire de Chine] ; Christian Delles [Royaume-Uni] | ACE2 the Janus-faced protein - from cardiovascular protection to severe acute respiratory syndrome-coronavirus and COVID-19. |
| 000A18 |
Sin-Yee Fung [Hong Kong] ; Kit-San Yuen [Hong Kong] ; Zi-Wei Ye [Hong Kong] ; Chi-Ping Chan [Hong Kong] ; Dong-Yan Jin [Hong Kong] | A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses |
| 000A45 |
Yung-Fang Tu [Taïwan] ; Chian-Shiu Chien [Taïwan] ; Aliaksandr A. Yarmishyn [Taïwan] ; Yi-Ying Lin [Taïwan] ; Yung-Hung Luo [Taïwan] ; Yi-Tsung Lin [Taïwan] ; Wei-Yi Lai [Taïwan] ; De-Ming Yang [Taïwan] ; Shih-Jie Chou [Taïwan] ; Yi-Ping Yang [Taïwan] ; Mong-Lien Wang [Taïwan] ; Shih-Hwa Chiou [Taïwan] | A Review of SARS-CoV-2 and the Ongoing Clinical Trials. |
| 000B06 |
Hadis Fathizadeh ; Parham Maroufi [Iran] ; Mansooreh Momen-Heravi [Iran] ; Sounkalo Dao [Mali] ; Kran Köse [Turquie] ; Khudaverdi Ganbarov ; Pasquale Pagliano [Italie] ; Silvano Esposito [Italie] ; Hossein Samadi Kafil [Iran] | Protection and disinfection policies against SARS-CoV-2 (COVID-19). |
